Frontlight ResearchEarly access
Trial site
Adana Sehir Egitim ve Arastirma Hastanesi
- 13running trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Lung cancer6 trials
- Obesity3 trials
- Chronic kidney disease1 trial
- Colorectal cancer1 trial
- Fatty liver disease (MASLD/MASH)1 trial
- Heart failure1 trial
- Metastatic breast cancer1 trial
- Stroke1 trial
- Type 2 diabetes1 trial
- Phase
- Phase 38 trials
- Phase 14 trials
- Phase 21 trial
- Status
- Recruiting9 trials
- Active, not recruiting4 trials
- Lead sponsor
- Amgen8 trials
- Eli Lilly and Company2 trials
- Pfizer2 trials
- Hoffmann-La Roche1 trial
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
A Phase 2 Study of Anvumetostat in Participants With MTAP-deleted Advanced NSCLC (MTAPESTRY 201)
Recruiting
Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer4 recruiting
- Obesity2 recruiting
- Chronic kidney disease1 recruiting
- Colorectal cancer1 recruiting
- Fatty liver disease (MASLD/MASH)1 recruiting
- Heart failure1 recruiting
- Stroke1 recruiting
- Type 2 diabetes1 recruiting
Site data: ClinicalTrials.govUpdated 12 Nov 2026